Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07780162 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Wearable Sensor for Early Detection and Monitoring of Cognitive Decline

StatusNot Yet Recruiting
PhaseNot specified
SponsorBioSensics
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description revisedv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
BioSensics
8 trials monitored
See 1 trial at risk
This observational study will enroll approximately 100 participants evenly split by cognitive status (Cognitively Impaired vs Non-Cognitively Impaired), and involves four clinic visits over one year (at baseline, 3, 6, and 12 months), each followed by 7 days of remote monitoring to assess the long-term feasibility of PAMSys+ (Physical Activity Monitoring System).
Trial Details
NCT Number NCT07780162
Lead Sponsor BioSensics
Collaborators: University of California, Los Angeles, National Institutes of Health (NIH)
Conditions
(from sponsor)		 Mild Cognitive Impairment (MCI), Older Adults With Cognitive Decline, Older Adults
Related terms Cognitive Dysfunction
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov